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Safety evaluationA combination of in vitro and in vivo experiments with comparative phage genomics was used for the
rational design of a phage cocktail against E. coli diarrhea. Orally applied T4 coliphages representing three
different subgroups (T4-, RB49- and JS98-like phages) had no negative impact on the murine gut microbiota.
T4 phages were found with high titers in the cecum and colon and lower titers in the small intestine, but
were not detected in the blood, liver or spleen. No adverse effects were observed after one-month exposure
to phage nor were serum anti-T4 antibodies detected. T4 phages belonging to the same subgroup showed
closely related genomes that differed by 12 (phage JS10 vs. JS98 reference) to 17 (phage JSE vs. RB49
reference) insertion/deletions mostly representing single small ORFs. Bioinformatic analysis did not reveal
undesired genes in the T4 genomes. Sequence variability was seen over the tail ﬁbre genes, but the variability
did not correlate with phage host range. The investigated T4 phages were not only species- but also strain-
speciﬁc, necessitating the use of phage cocktails consisting of 10 and 16 T4 phage isolates to cover half to two
thirds of E. coli strains representing the ﬁve main pathotypes isolated from diarrhea patients.© 2009 Elsevier Inc. All rights reserved.IntroductionThe increase of antibiotic resistance in a number of medically
important bacterial pathogens limits the successful application of
antimicrobial chemotherapy in clinical practice. The threat of an
antibiotic crisis has revived the interest in diverse biological
approaches against infectious diseases, including the use of phages
against bacterial infections (Merril et al., 2003). The idea of phage
therapy was introduced at the beginning of the last century by the
discoverer of phages Felix d'Hérelle (Kutter and Sulakvelidze 2005).
The ﬁrst clinical trials gave variable results due to the unknown nature
of phages and inadequate quality of the phage preparations. Never-
theless, these early efforts led to commercial phage products by US
American pharmaceutical companies in the 1930s, sometimes,
however, with doubtful claims. Subsequently, phage therapy against
diarrheal diseases and wound infections was empirically, but system-
atically developed in the Soviet Union (Sulakvelidze et al. 2001).
Numerous phage preparations are now sold as registered medicine in
Russian pharmacies. However, neither the clinical trials conducted
with these phage products nor the phages contained in these
preparations were described in detailed scientiﬁc publications. Care-
fully documented veterinary work in the Western hemisphere
demonstrated the potential of phage therapy against E. coli diarrhea
in cattle (Smith et al. 1987a,1987b) and E. coli respiratory infections in
chicken (Huff et al., 2002; 2005). However, these phages were not. Brüssow).
ll rights reserved.described in detail either. Therefore it is not clear yet what phage
properties are necessary for successful phage therapy.
Phage therapy approaches have to address a number of issues
before human clinical trials can be considered (Brüssow 2005). To
develop its full potential as a therapeutical or prophylactic anti-
microbial agent, phage must infect the target pathogen in its
epidemiological diversity, but spare commensal bacteria. For an easy
oral application, phage must survive unprotected gastrointestinal
passage. In addition, phage should stay sufﬁciently long and with high
enough titer at the replication site of the pathogen to achieve its in
vivo lytic activity. Finally, phages should not cause adverse side effects
and their genomes should not carry virulence factors or undesired
genes like antibiotic resistance genes, which they could transfer to the
infected host. In the following we investigate whether these
conditions are fulﬁlled for the molecularly well characterized
(Karam 1994) T4-like coliphages.
Results and discussion
No impact of oral T4 phage on commensal microbiota in mice
Since phages are in general species-speciﬁc, phage application
should not affect non-target bacteria thus avoiding the collateral
damage induced by antibiotics on bystander bacteria. This aspect may
not be a major concern when phages are used for the treatment of
acute diarrhea since under these conditions the gut microbiota is
already disturbed by the disease process. However, the speciﬁcity of
phages becomes important during prophylactic oral application of
phages.
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22 E. Denou et al. / Virology 388 (2009) 21–30We tested the impact of T4 phages on the gut microbiota when
given orally to healthy conventional mice. On blood agar, the
anaerobic cultivable microﬂora of control conventional C3H mice
showed 1011 cfu (colony forming units) per gram of feces. On this
medium mice yielded the following bacterial titers (in cfu/g of gut
content) along the gastrointestinal tract: 107 (fore-stomach, mainly
lactobacilli), 105 (duodenum), 107 (jejunum), 108 (ileum), 1010
(cecum), 109 (upper colon) and 1010 (lower colon). On Drigalski
agar, a more speciﬁc medium for enterobacteria (Chibani-Chennouﬁ
et al. 2004b), we detected 106 cfu/g gut content in the cecum and the
large intestine, while only low numbers were counted along the small
intestine (≤102 cfu/g in most samples) and intermediate values were
found in the fore-stomach. Notably, mice treated with representatives
of three subgroups of T4 phages (Comeau et al., 2007; Desplats et al.,
2002; Nolan et al. 2006; Zuber et al., 2007) showed an identical
intestinal distribution of bacterial counts on blood and Drigalski agar
(data not shown) as untreated control mice thus excluding a gross
effect of oral T4 phages on gut commensals in mice.
Simple plating methods give only a small picture of the
microﬂora. One might ask whether plating tests are sensitive enough
to reveal microbiota changes after interventions. Therefore we
treated conventional mice with antibiotics (10 μg/ml erythromycin
plus 25 μg/ml chloramphenicol) in their drinking water. These mice
showed a marked reduction of the fecal microbial ﬂora. For example,
the count of lactobacilli dropped from 109 cfu/g feces in control mice
to 104 cfu/g feces in antibiotics-treated mice (Denou et al., 2008).
However, due to substantial antibiotic resistance of diarrhea-causing
E. coli strains (Djie-Maletz et al., 2008), antibiotics are now
infrequently used clinically for the treatment of E. coli diarrhea,
which is mainly symptomatic.
This lack of an impact of oral T4 coliphage on the murine gut
microbiota was not surprising since an API sugar fermentation gallery
identiﬁed the major colony types recovered from Drigalski agar plates
as Klebsiella sp. No characteristic E. coli colonies were detected when
fecal material was plated on the more selective EMB medium.
Furthermore, when we picked 500 colonies, none showed in vitro
susceptibility towards these three T4 phages (data not shown).
In vitro host range of T4 phages on pathogenic E. coli strains
While the host species-speciﬁcity of phages is a clear asset for
phage therapy, many phages are not only species- but also strain-
speciﬁc. The narrow host range of phages becomes a potential liability
when a reasonable coverage of the targeted pathogen has to be
achievedwith a small phage cocktail. Table 1 illustrates this point with
T4 phages representing four of the ﬁve known subgroups of T4
coliphages whose genomes were all sequenced (Comeau et al., 2007;
Desplats et al., 2002; Nolan et al. 2006; Zuber et al., 2007; this
manuscript). These phages were tested against a panel of entero-
pathogenic (EPEC) and enterotoxigenic (ETEC) E. coli strains of known
O, H and K serotype collected at the Division of Enteric Pathogens of
the Central Public Health Laboratory, Enteric division, Colindale,
London/UK during the 1970s (kindly provided by B. Rowe) associated
with infant diarrhea (Levine and Edelman, 1984; Qadri et al., 2005).
Only a few T4 phages showed a relatively broad host range on the
pathogenic E. coli test strains like phage RB49, which lysed 8 of the 25
test strains. The other investigated T4 phages lysed only four or less of
the test strains. In this example a cocktail of six T4 phages lysed 13 out
of the 25 (52%) investigated E. coli pathogens.
Clinicians from the International Center for Diarrheal Diseases
Research at Dhaka/Bangladesh (ICDDR,B) provided us with 46
epidemiologically independent pathogenic E. coli isolates, which
were recovered from patients hospitalized in 2008 with acute
diarrhea at their institution (F. Qadri, S. Sarker and A. Cravioto,
ICDDR,B). These isolates represented ﬁve different pathotypes of
E. coli, namely 10 enteroaggregative strains (EAggEC), 3 enteroinva-
Fig.1. T4 phage distribution along the different gut segments of mice fed with 109 pfu T4 phage cocktail in drinking water (top panel) and inmice fed with the same amount of phage,
which received in addition 1010 cfu of E. coli K-12 by intra-gastric feeding (bottom panel). The ordinate indicates the log10 pfu/g for ﬁve individual mice (A1 to A5 and B1 to B5
represent individual mice); the numbers at the abscissa indicate the gut segments (1: extract and 2: scraping of stomach; 3: wash and 4: scraping of duodenum; 5, 6 and 7, 8 wash
and scraping of proximal and distal jejunum, respectively; 9, 10 and 11, 12 and 13, 14 wash and scraping of proximal, medial and distal ileum, respectively; 15: extract of cecum; 16, 17
and 18, 19 extract and scraping of proximal and distal colon, respectively). Where no bar is indicated in the ﬁgure, no phage was detected.
23E. Denou et al. / Virology 388 (2009) 21–30sive strains (EIEC), 15 EPEC strains, 3 verotoxin-producing E. coli
strains (VTEC) and 15 ETEC strains. Against these pathogenic E. coli
strains, the cocktail showed only 18% coverage suggesting temporal
changes in the E. coli epidemiology (Harris et al., 2008; Stoll et al.,
1983). We screened our T4 phage collection, which comprises about
140 ecologically independent T4 phage isolates (Chibani-Chennouﬁ
et al., 2004a; Zuber et al. 2007) against the pathogenic E. coli collec-
tion from ICDDR,B. With a cocktail consisting of 10 phages we
achieved 52% coverage of this pathogen collection. Only two phage
isolates lysed each 6 distinct pathogenic E. coli strains. One, three and
four phage isolates lysed three, two and one pathogenic E. coli strains,
respectively. A coverage of two thirds of the pathogenic E. coli strains
from the ICDDR,B collection necessitated a cocktail consisting of
sixteen T4 phage isolates demonstrating that pathogen coverage is an
issue in phage therapy approaches against E. coli diarrhea. This same
16-phage cocktail showed a 53% coverage against a collection of 40
distinct pathogenic E. coli strains isolated from 321 children living in
Dhaka/Bangladesh followed prospectively in the community fordiarrhea episodes not leading to hospitalization over their ﬁrst two
years of life (Qadri et al., 2007).
Gastrointestinal passage of oral phage
Next we asked for the gut survival of phage added to the drinking
water. When mice received a phage preparation consisting of three
different subgroups of T4 phages at a dose of 109 plaque forming
units (pfu)/ml drinking water, phage titers up to 106 pfu/g gut
content were detected in the cecum and the large intestine. The
titers were thus 1000-fold lower than in the drinking water. Even
when accounting for dilution effects by secretions into the gastro-
intestinal tract, a sizable loss of phage must have occurred. A possible
barrier could be the mouse stomach where the acidity can drop to a
pH of 3. However, a much lower dose of 105 pfu/ml of phage in
drinking water led to phage detection in all feces samples of adult
human volunteers (Bruttin and Brüssow 2005), who display stronger
gastric acidity drops than mice. It is thus not clear whether phage
Fig. 2. Genome alignment of the RB49-like coliphage JSE isolated from sewage in Switzerland (center) with coliphage RB49 (top), the reference phage for a subgroup of T4 coliphages, which was isolated from sewage in the USA, and coliphage
JS98 (bottom), the reference phage from another subgroup of T4 coliphage, which was isolated from a pediatric diarrhea patient in Dhaka/Bangladesh. The DNA sequence comparison is visualized with the Artemis Comparison Tool (ACT)
developed by the Sanger Center (http://www.sanger.ac.uk/Software/ACT/) (Rutherford et al., 2000) using BlastN E-values b10−3. The ORFs are indicated by arrows starting with the rII gene at the left side of the map.
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25E. Denou et al. / Virology 388 (2009) 21–30must be given together with a bicarbonate buffer to achieve high in
situ concentrations.
In the phage-fed mice, phage titers in excess of 104 pfu/g content
were found in the stomach. In the small intestine titers were equal or
less than 104 pfu/g gut content and more than half of the samples did
not show phages (detection limit was 50 pfu/g material) (Fig. 1A).
Due to the rapid transit time only low amounts of luminal material
was recovered from the small intestine. In patients with acute
diarrhea, oral phages will thus only have a very short in situ contact
time with the E. coli pathogen.
In vivo replication of oral phage
Subsequently we explored the replication of oral phage on target
E. coli cells in the gut. As our conventional mice lacked E. coli target cells
in the gut, we introduced 1010 cfu of the phage-susceptible indicator E.
coli strain K-12 by intra-gastric force-feeding. Four hours later the mice
were dissected. Mice which received K-12, but no oral phage showed E.
coli titers between105 and108 cfu/g in the cecumand colonand105 cfu/
g or less in the small intestine. Test mice (K-12 fed plus T4 phage in the
drinking water) showed higher intestinal phage titers thanmice, which
received identical phage concentrations, but no K-12 feeding (compare
Fig. 1B with Fig. 1A). The phage titer increase was 1000-fold in the
jejunum and proximal ileum, but only 10 to 100-fold in the distal ileum
and the large intestine. Oral phage had no impact on E. coli titers in the
stomach, cecum and colon, while no K-12 was observed in the small
intestine of phage-treated mice (data not shown). There is currently no
mouse model to test the in situ replication of phage under conditions
resembling an E. coli diarrhea. A mouse model exists for Citrobacter
rodentium (Borenshtein et al., 2008) but not for E. coli in mice (but see
Tanji et al. 2005). For the enterohemorrhagic E. coli strain O157:H7 a
modelwas developed in rabbits (Ritchie et al., 2003; Ritchie andWaldor,
2005). Our phage cocktails displayed no lytic activity against these
pathogens precluding the use of these models.Fig. 3. Genome map alignment of RB49-like coliphages. (A) Alignment of the genomemaps o
sequence is from Nolan, J.M., Department of Biochemistry, Tulane University Health Sciences
Biology Database Collection entry number 750 (http://www3.oup.co.uk/nar/database/sum
all three phages. The lower three rows highlight the regions where differences in the genom
ORFs are found at different positions along the map, they are highlighted with the same c
different subgroups of T4 coliphages. The ORFs are indicated by arrows starting with the rII
sequence sharing is explained by the color scale at the bottom of the ﬁgure.Safety of oral T4 phage in mice
Representatives of three different subgroups of T4 coliphages were
given to conventional 6-week-old female C3H mice both individually
and as a cocktail. The phage was orally applied at the high dose of
109 pfu/ml drinking water over one month. No adverse events were
observed, and mice showed normal weight gain and normal
behaviour (data not shown). At the end of the experiment, no phages
were detected in blood, liver and spleen samples when using plaque
assays (detection limit 50 pfu/g). Serum antibodies against T4 phage
were searched in phage-exposed mice using two tests (murine Ig-
speciﬁc ELISA on T4 phage-coated plates and neutralization test using
the plaque reduction test with T4). No signiﬁcant T4-speciﬁc antibody
increase was seen for paired serum samples taken before and four
weeks after oral phage exposure (data not shown). Furthermore, by
macroscopic observation the gastrointestinal tract of the phage-
treated mice did not reveal evidence of inﬂammation. The innocuous
nature of phage T4 was previously also demonstrated in human
volunteers receiving this phage in their drinking water (Bruttin and
Brüssow, 2005). An integral part of a safety analysis of phages should
also be their in silico genome analysis as detailed in the following
paragraphs.
Genome sequence of the RB49-like phage JSE
T4-like phages were the target of a genome sequencing project
(http://phage.bioc.tulane.edu). At least one representative of each of
the ﬁve subgroups was sequenced and comparative genomics
analyses were published (Comeau et al., 2007; Chibani-Chennouﬁ
et al., 2004c; Desplats et al., 2002; Nolan et al. 2006; Zuber et al.,
2007). A detailed “genomic safety” analysis of one representative T4
phage did not revealed undesired genes in its genome (Zuber et al.,
2007). Now we asked what genetic diversity is encountered in T4-
like coliphages belonging to the same subgroup. To answer thisf the RB49-like coliphages JSE, RB49 and phi1 (http://phage.bioc.tulane.edu). The phi1
Center, New Orleans, LA 70112, USA listed in T4-like genome database in NARMolecular
mary/750). The top row shows those parts of the genomemap that are shared between
e map were observed between the three phages depicted individually. Where related
olor. (B) Alignment of genome maps of coliphages JSE and JS98, which represent two
gene at the left side. ORFs sharing aa identity are linked by color shading; the degree of
Fig. 4.Genome alignment of the JS98-like coliphage JS10 isolated from a pediatric diarrhea patient in Dhaka/Bangladesh (center) with coliphage RB49 (top) and coliphage JS9 ottom), whichwas also isolated from a pediatric diarrhea patient
in Dhaka/Bangladesh. The DNA sequence comparison is visualized with the Artemis Comparison Tool (ACT) using BlastN E-values b10−3. The ORFs are indicated by arrow tarting with the rII gene at the left side of the map.
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Table 2
Percentage of amino acid identity between the tail ﬁbre proteins gp34 (above the
diagonal) and gp37 (below the diagonal) of the indicated T4-like coliphages.
Gp37/gp34 T4 RB32 RB69 JS98 JS10 RB49 JSE
T4 – 91 70 51 51 37 37
RB32 (76) – 70 51 51 36 43
RB69 34 (71) – 51 52 36 36
JS98 34 (67) 75 – 96 42 42
JS10 32 (35) 64 61 – 38 38
RB49 35 49 36 32 21 – 98
JSE ((44)) (49) (35) (38) (35) 71 –
Numbers in parenthesis: identity is only over part of the proteins; double parenthesis:
only short region of alignment. Bold numbers are the highest identity percentages
within a subgroup of T4 coliphages, bold numbers in italics are the highest identities
between subgroups of T4 coliphages.
27E. Denou et al. / Virology 388 (2009) 21–30question we sequenced the genome from the T4-like coliphages JSE
and JS10.
Phage JSE is a member of the RB49-subgroup of T4 coliphages. JSE
was isolated in 2000 from a sewage station in Switzerland, while
RB49 was isolated more than 40 years ago from a sewage plant in the
USA (Russell 1974). JSE yielded a 166,418 bp-long genome sequence
in a single contig. In an ACT nucleotide comparison the JSE genome
sequence could be aligned with the DNA sequence of phage RB49
(Comeau et al. 2007; Desplats et al. 2002) essentially over the entire
genome length (Fig. 2). In sharp contrast, phages JSE and JS98, which
belong to two different subgroups of T4-like coliphages, showed only
limited DNA sequence sharing in the ACT comparison (Fig. 2).
However, at the protein level, substantial sequence identity was still
observed between JSE and JS98, particularly over the structural gene
cluster (Fig. 3B) which represents the core region of the T4 phage
family (Comeau et al., 2007; Filée et al., 2006). The conserved
genome region shared between phage JSE and JS98 was, however,
smaller than that shared across other T4 subgroups (Zuber et al.,
2007).
Phages JSE and RB49 differed by 17 insertions/deletions (Fig. 2).
Most of them covered a single ORF (Fig. 3A) and represented small
hypothetical ORFs and two encoded homing endonucleases. Overall
the difference between independent RB49-like phages was small even
when including a third phage phi1 from the Tulane database into this
comparison (Fig. 3A). One larger variable region encoded the
homologues of the T4 baseplate wedge protein gp11, the short tail
ﬁbre gp12 and the neck whisker gpwac. Another region with
substantial sequence variability covered the tail ﬁbre genes g34 to
g37. Two split genes (Petrov et al., 2006) were observed when JSE
was compared with RB49. The ﬁrst was JSE ORF27 and 28, encoding,
respectively, the N-terminal and the C-terminal halves of gp43 T4 DNA
polymerase, separated by 480 bp without database match. The second
split gene in JSE was ORF57 and 59 encoding two parts of an anaerobic
ribonucleotide reductase, separated by an endonuclease gene
(ORF58).
Genome sequences of JS98-like phages JS10 and JSD1-4
Like JS98 phage JS10 was isolated from the feces of a diarrhea
patient in Bangladesh while JSD1-4 is an environmental water isolate
from Bangladesh. JS10 yielded a 171,451 bp-long genome sequence in
a single contig. In an ACT nucleotide comparison the JS10 genome
sequence could be aligned with the DNA sequence of phage JS98 over
the entire genome length, while only small regions of DNA sequence
identity were shared with phage RB49 (Fig. 4). The JS10/JS98
alignment showed 12 insertions/deletions (Fig. 5). Most of them
represented single and small ORFs including the large outer capsid
protein gene hoc, the alt gene-homologue encoding an adenosylribo-
syltransferase, and motB, whose gene product interacts with MotA
(Miller et al. 2003). One large region of variability covered the
adjacent tail ﬁbre genes g37 and g38, gene t, encoding the phage
holin, and asiA, encoding a protein that facilitates interaction of the
MotA activator with T4 phage middle promoters (Miller et al., 2003).Fig. 5. Inter- and intra-subgroup alignments between T4-like coliphages. The top row shows
second and third rows give the T4-speciﬁc and JS10-speciﬁc ORFs, respectively, from the inte
JS10-speciﬁc and JS98-speciﬁc ORFs, respectively, from the intra-subgroup comparison betw
the left side of the map.Phage JSD1-4 yielded 148,778 bp of partial sequence information
coming in 82 contigs. Due to its close similarity with the JS98 genome
sequence, the numerous JSD1-4 contigs could be easily ordered along
the JS98 genome (Supplementary Fig. 1).
The tailﬁbres of T4 contain the anti-receptor reactingwith the cellular
receptor,which is frequently the lipopolysaccharide (LPS) ofE. coli (Tétart
et al., 1996). The large proximal tail ﬁbre subunit protein gp34 showed
high protein sequence identity between phages from the same subgroup
(91–98%) and much lower identity across the subgroups displaying a
clear gradient (Table 2). Surprisingly, thehighest level of aa identity of the
large distal tail ﬁbre subunit protein gp37, which is annotated as the
phage adhesin, was observed between JS98 and RB69, which represent
two different T4 phage subgroups and which show clearly distinct host
speciﬁcities (Table 2). Apparently, the interaction of the tailﬁbrewith the
bacterial receptor is not the only host range determinant, although it
deﬁnitively plays a primary role (Tétart et al., 1998).
“Genomic safety” of T4 phages
For all but ten of the 277 predicted JSE proteins the closest database
match was with phage RB49 (Supplementary Table 1); ﬁve of these ten
proteins were annotated as homing endonucleases, suggesting an intro-
duction of selﬁsh DNA elements into the JSE genome as was previously
observed inT4phage (Quirket al.,1989). Threeproteins showed linkswith
T4-like coliphage phi1, two proteins lacked database matches.
No DNA sequence identitywas detected between JSE and E. coli, thus
excluding recent gene transfer between phage and its bacterial host.
Nineteen JSE proteins shared protein sequence identity b60%with E. coli
(Supplementary Table 2); 17 of these 19 proteins also had a matchwith
T4 phage genes. Fifteen JS10 proteins shared b54% aa sequence identity
with E. coli proteins; 13 of them showed a better alignmentwith T4-like
phages (Supplementary Table 3). Finally, we screened the JSE and JS10
genome sequences against a database of harmful or undesired genes
(DUG), aswell as against a list of virulence genes identiﬁed inprophages
from bacterial pathogens (Boyd and Brüssow, 2002; Brüssow et al.,
2004; Canchaya et al. 2003) and against an allergen database (see
Materials and methods). No suspicious gene matches were thus
identiﬁed.those parts of the genome map that are shared between T4, JS10 and JS98 phages. The
r-subgroup comparison between phages T4 and JS10. The fourth and ﬁfth rows give the
een phages JS10 and JS98. The ORFs are indicated by arrows starting with the rII gene at
28 E. Denou et al. / Virology 388 (2009) 21–30In the construction of the DUG database more than 300 keywords
were used.Most of themcovered antibiotic resistancegenes,while toxin
and virulence genes were only represented by generic terms. Since
virulence is not well deﬁned, one might question the efﬁcacy of such
searches compared to direct searches of the individual phage genes
against the large online public databases. We used prophages from the
E. coli strain O157:H7, which contain biologically proven virulence genes
(Tobe et al., 2006), as a test case with the DUG database. The DUG
screening demonstrated Shiga toxin, cytotoxin, verocytotoxin, and a
complement resistance factor in a short hit list. Blast searches against
the NCBI database identiﬁed Shiga toxin, cytotoxin and an LEE effector.
Both methods are of comparable sensitivity, but a DUG search is done
quicker. However, this becomes only a clear advantage when numerous
phages or larger bacterial genomes (for which DUGwas developed) are
screened for undesired factors.
Conclusion
T4 phages are professional virulent phages that propagate by serial
lytic infection cycles and do not establish a lysogenic state. Since T4
phages destroy the bacterial DNA during the infection process, the
transfer of undesired genes via lysogenic conversion or transduction is
thus unlikely.Within subgroups of T4 coliphages thephage genomes are
well conserved andnoundesired geneswere identiﬁed by bioinformatic
analysis. In addition, oral T4 phages did not lead to adverse effects in
animals or humans making T4 suitable candidates for phage therapy.
More questions have still to be answered with respect to the efﬁcacy of
T4 use. Since noT4 phages with a broad host range on pathogenic E. coli
were identiﬁed, phage approaches against E. coli diarrhea necessitate
the use of phage cocktails. Phages are a potentially self-amplifying
antimicrobial agent when they meet their target cells in vivo. Therefore
it is not clear whether the low phage titers established in the small
intestine, i.e. the site where the disease process of E. coli diarrhea occurs
in humans, are sufﬁcient to assure an in situ replication on the pathogen.
The only modest ampliﬁcation of T4 phages in the gut, which we
observed, reﬂects more the limitation of our mouse model with respect
to anE. coli infection in the gut than an intrinsic low replicationpotential
of T4 phages in vivo.
Materials and methods
Sequencing
Phage DNAwas ampliﬁed by an emulsion-basedmethod, sequenced
by synthesis using a pyro-sequencing protocol (Margulies et al., 2005)
and phages JS10 and JSE were de novo assembled into a single contig by
454 LifeSciences Corp (Branford, Connecticut, USA). About 60,000 reads
per phage were assembled into a single contig. Since the sequence did
not contain repeats, the assembly was straightforward. Most reads
showed lengths of between 100 and 140 bp (mean at 110 bp) and the
coverage of the sequencing varied from10- to 70-fold (mean30-fold). In
regions of b30-fold coverage, a 30-bp overlap of at least 10 readingswas
achieved. Previously we compared the sequence of a T4-like phage
obtained with the pyro-sequencing protocol with that obtained for
shearedphageDNAcloned into theplasmidvector pUC18, propagated in
E. coli and sequenced by the Sanger method. We observed 99.97%
sequence identity; discrepancies were mostly resolved in favor of the
pyro-sequencing method (Zuber et al., 2007). The sequence data were
deposited at GenBank under accession number EU863408 for JSE and
EU86409 for JS10.
Bioinformatics analysis and annotation
Genome sequence comparisons were carried out using the
MUMmer package (version 3.18) (http://www.tigr.org/software/
mummer) (Kurtz et al., 2004) and EMBOSS (The European MolecularBiology Open Software Suite, version 4). We used the Artemis
software (version 9) as sequence viewer and annotation tool
(Rutherford et al., 2000). ORFs were predicted using the Glimmer
software (version 3.02) (Delcher et al., 1999) and based on nucleotide
and amino acid sequence alignment searches (BlastN, TBlastN, BlastX
and BlastP), using the T4-like genome database available through the
Tulane website (http://phage.bioc.tulane.edu) and the non-redun-
dant database (nr) from NCBI. The basic prerequisites for an ORF were
the presence of one of the three potential start codons ATG, TTG or
GTG, and a length of at least 25 encoded amino acids. A search for
tRNA genes was done with the tRNAscan-SE program (version 1.23)
(Lowe and Eddy, 1997). Homology assignments between genes from
other T4-like phages and predicted ORFs of phage JSE and JS10 were
based on amino acid sequence alignment searches (BlastP) and were
only accepted if the statistical signiﬁcance of the sequence similarities
(E-value) was ≤0.001, the bit score ≥50 and the percent identity
between the aligned sequences (% id) ≥30%. Functional annotations
were based on the homology assignments with the T4 genes and
functional classiﬁcations were performed using the COG (Clusters of
Orthologous Groups of proteins) database (Tatusov et al. 1997). We
used the ACT (Artemis Comparison Tool, version 6) to compare closely
related genomes. Comparisons between two genomes were based on
nucleotide sequence alignments searches (BlastN) (E-value ≤0.001
and bit score≥100). The minimal length to determine supplementary
and variable DNA regions was 100 nucleotides.
Genetic safety screening
The Database of Undesirable Genes (DUG) was built in the
following way. A list of terms related to antibiotics, virulence, and
toxins, comprising a total of 314 items, was deﬁned. Then, the EMBL
public sequence database (only the prokaryote and phage subsets) is
screened based on these terms. For all EMBL coding sequence (CDS)
ﬁles, the terms are searched in the following features: “description”,
“product”, and “note”. If one of the terms is found, the protein and its
related nucleotide sequences are added to the DUG_protein and the
DUG_nucleotide databases respectively. Next a set of experimentally
proven sequences known to be involved in antibiotic resistance is
added to the sequences collected from EMBL. All sequences in the DUG
databases are in FASTA format. Their title line contains the description
of the gene or protein, the speciﬁc term which was found and the
organism name. Then, the two DUG databases are made non-
redundant (http://blast.wustl.edu/pub/nrdb/). The database is
updated at bimonthly intervals. BlastP and BlastN searches were
performed against the DUG and against 15 E. coli genomic sequences.
Only hits with an E-value ≤0.01 (BlastP and BlastN) and a bit score
≥50 (BlastP) were considered to constitute signiﬁcant matches.
The predicted phage proteinswere screened for similarities against
known protein food allergens in the Food Allergy Research and
Resource Program at http://www.allergenonline.com.
Host range
The lysis test in tubes was done against a representative collection
of enteropathogenic and enterotoxigenic E. coli serotypes as described
previously (Chibani-Chennouﬁ et al. 2004b).
Animal experiments
Adult female conventional C3H mice were separated into insula-
tors. All mice received the speciﬁed phage in sterile Vittel mineral
water. Phages were propagated on E. coli strain K-12 inoculated into
Hershey medium. The lysate was cleared by centrifugation and passed
through a 0.22 μm Millipore ﬁlter. The T4 phages were then pelleted
by ultracentrifugation (35,000 ×g for 25 min) and resuspended in
Vittel water.
29E. Denou et al. / Virology 388 (2009) 21–30After the oral feeding of phage with the drinking water and if
indicated the intra-gastric feeding of the indicator K-12 E. coli strain,
fecal samples were collected and the mice were at the indicated time
points anaesthetized with isoﬂurane and killed by bleeding. A blood
sample was collected into a heparin tube. Liver and spleen were
dissected as well as the stomach, duodenum, jejunum (2 segments),
ileum (3 segments), cecum, and colon (2 segments). The stomach,
cecum and colon contents were extracted and the small intestine
content was recovered bywashingwith a syringe. After extraction and
washing themucosa layer was collected from all gut segments (except
the cecum) by scraping. The presence of phage was determined by the
double-layer agar plaque assay on Hershey agar. The bacterial counts
were determined on blood agar, Drigalski or EMB medium according
to the indications of the supplier (Difco). The identity of selected
colonies was further determined on an API sugar fermentation gallery.
Food intake, mobility, change in behaviour and physical appearance of
the mice was noted by the workers in the animal house. The gross
anatomy of the gut and other vital internal organs was noted during
the dissection of the mice.
ELISA was essentially done as described (Brüssow et al. 1988)
except that puriﬁed T4 phage antigen was coated on the plates and a
polyvalent anti-murine Ig conjugate was used. Neutralizing anti-T4
serum antibodies were determined with a plaque reduction test. A T4
phage preparation titrated to yield 100 pfu on a plaque assay was
incubated before plating with a series of de-complemented serum
dilutions at 37 °C for 30 min. The serum dilution yielding a greater
than 50% plaque reduction was considered as neutralizing.
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